Document is current
Any future updates will be listed below
-
Authors
Hübel, Kai
-
Funding
Funding for this research was provided by:
Novartis Pharma AG
- License Information
-
More Information
Article History
Received: 22 August 2023
Accepted: 28 February 2024
First Online: 21 March 2024
Declarations
:
: Kai Hübel: Consultant: AbbVie, Recordati, Gilead, Incyte, Novartis, Roche; Speaker’s Bureau: AbbVie, BeiGene, Recordati, Incyte, Sanofi, Roche; Scientific Advisory Board: AbbVie, Roche, Sanofi, BMS, Recordati, Novartis, Miltenyi Biotec; Research Support: Roche, Gilead, Incyte.
: Ethical approval was not applicable for this vodcast.
